Quantros Patient Safety Center Receives Certification as a Patient Safety Organiza... ( SAN FRANCISCO Dec. 8 /- Quantros a le...)

Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO)

Date:12/8/2008

SAN FRANCISCO, Dec. 8 /PRNewswire/ -- Quantros, a leading provider of safety, quality, and compliance solutions for the healthcare industry, today announced that the Agency for Healthcare Research and Quality (AHRQ) has granted initial certification to Quantros Patient Safety Center as a Patient Safety Organization (PSO). The listing can be viewed at http://www.pso.ahrq.gov/listing/psolist.htm. The Quantros Patient Safety Center is a new division within Quantros that is specifically focused on review of safety processes, data analytics, and provision of associated knowledge content and complementary services to support healthcare providers using Quantros as a PSO to better address patient safety. Supporting healthcare providers in the improvement of safety and quality initiatives is in complete alignment with the mission and goals of the organization for more than nine years. Today more than 2,000 healthcare providers use one or more Quantros solutions for improving safety and quality within their care environment.

In addition to the Quantros Patient Safety Center, Quantros also supports other entities acting as a PSO with Quantros Patient Safety Organization (PSO) Manager, a streamlined, Web-based application that will enable PSOs to seamlessly aggregate required Common Format (CM) for event data as well as additional safety data for use as a confidential Patient Safety Work Product (PSWP). Just as with The Joint Commission ORYX Core Measures program, Quantros has chosen to act as both a technology provider and a PSO.

Dr. Sanjaya Kumar, Quantros President and CEO commented, "Quantros is in business to assist healthcare providers in advancing safety and quality improvement initiatives. The Quantros Patient Safety Center was created to further that cause for healthcare providers who want to leverage both Quantros and associated partner experti
'/>"/>

SOURCE Quantros
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine news :

1. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
2. Quantros Expanding Support for Alternative Web Browsers
3. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
4. Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial
5. Electronic Prescribing Saves Patients Money
6. Confusing risk information may lead breast cancer patients to make poor treatment choices
7. Marital problems lead to poorer outcomes for breast cancer patients
8. Vitamin B1 could reverse early-stage kidney disease in diabetes patients
9. Lenalidomide safe as single therapy for elderly CLL patients
10. Dieticians & Nutritionists Concerned Economic Downturn Will Effect Patient Health and Diets.
11. CHOC Childrens Draws First Patient Dose With RIVA System

Post Your Comments:

(Date:1/22/2015)... 23, 2015 LunaDress, with its top dressmaking ... industry. Now, the business is showing its latest designs of ... , According to the company’s CEO, all the fresh new ... with big discounts, up to 80% off. All the clothes ...

(Date:1/22/2015)... 2015 Woodloch Pines, an all-inclusive family ... by TripAdvisor as the number one best large hotel for ... the world for their annual Travelers’ Choice Awards. , ... The website is home to millions of unbiased and honest ...

(Date:1/22/2015)... 22, 2015 Padre Murphy's and Owner Tom ... Pro Player Health Alliance (PPHA). The PPHA's passion ... getting everyone, including NFL greats, treated for obstructive sleep apnea ... groups supporting the cause in the valley. The most recent ...

(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...

(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...

Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2 Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2 Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3 Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2 Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3 Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2 Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2

[0] LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 [0] TripAdvisor Names Woodloch Pines Best Hotel for Families in America [0] Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring [0] The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released [0] Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless”

... , , , FOSTER ... WHAT: Siperian, Inc., a leading industry provider of a multidomain master ... IBM Global Business Services and Boehringer Ingelheim have teamed up for an ... Most Valuable?" Hussain Mooraj, vice president, Healthcare ...

... HONG KONG, Sept. 16 /PRNewswire-Asia/ -- At ... September 10, reporters were informed that the,First World Conference ... Physicians) and the First World Endoscopy Technology Expo,will be ... Professor Zhang Yangde, the chief ...

... HBV genotypes as well as mutations in the core promoter, ... association with the clinical outcome of liver disease, however, this ... the HBV genotype distribution in certain region. So far, there ... country with a big population and a relatively high HBV ...

... , , MENLO PARK, ... label-free technology that accelerates the development of biotherapeutic and pharmaceutical ... and Read Immunogenicity Assay Kit for rapid detection of anti-drug ... new assay kit provides life science researchers with new levels ...

... , , , NEW YORK, ... has received Orphan-Drug designation from the U.S. Food and Drug Administration ... announced that it had reached an agreement with the FDA regarding ... 3 trial in relapsed/refractory multiple myeloma and that the study is ...

... study finds supervised exercise has better results , WEDNESDAY, ... than shockwave treatment for relieving chronic shoulder pain, according ... used to treat shoulder pain, even though a number ... investigate, Norwegian researchers studied 104 men and women, aged ...

Cached Medicine News:Health News:Siperian to Host Webinar With Panel of Pharmaceutical Experts 2 Health News:Siperian to Host Webinar With Panel of Pharmaceutical Experts 3 Health News:Siperian to Host Webinar With Panel of Pharmaceutical Experts 4 Health News:Siperian to Host Webinar With Panel of Pharmaceutical Experts 5 Health News:The First World Conference of Endoscopy Physicians will be Held December 18-20, 2009, in Hong Kong 2 Health News:The First World Conference of Endoscopy Physicians will be Held December 18-20, 2009, in Hong Kong 3 Health News:ForteBio Launches Dip and Read(TM) Immunogenicity Assay Kit for Rapid Detection of Anti-Drug Antibodies 2 Health News:Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma 2 Health News:Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma 3 Health News:Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma 4 Health News:Shockwave Treatment May Not Be Best for Shoulder Pain 2

Siperian to Host Webinar With Panel of Pharmaceutical Experts The First World Conference of Endoscopy Physicians will be Held December 18-20, 2009, in Hong Kong HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia?ForteBio Launches Dip and Read(TM) Immunogenicity Assay Kit for Rapid Detection of Anti-Drug Antibodies Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma Shockwave Treatment May Not Be Best for Shoulder Pain

(Date:1/22/2015)... , Jan. 22, 2015 ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...

(Date:1/22/2015)... Jan. 22, 2015 Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today reported ... 31, 2014. Global revenue for the Company,s ... million, a new quarterly revenue record, as compared to ...

(Date:1/22/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... for cardiovascular disease and overall health is pleased to provide ... and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share with ...

[0] ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan [0] Uroplasty Reports Record Revenue in Fiscal Third Quarter [0] Pivotal Therapeutics: Year in Review and CEO Update

... Fla. and NEW YORK, Sept. 28 ... development company, announced today that it has completed ... Stock resulting in gross proceeds of approximately $6.5 ... Neil Flanzraich, also included current investors Wexford Spectrum ...

... (NYSE: BSX ) today welcomed the publication ... II clinical trial in the current issue of ... of implantable cardioverter defibrillator (ICD) therapy are sustained at ... data regarding the benefits of ICDs in a primary ...

Cached Medicine Technology:Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement 2 Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement 3 Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy 2 Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy 3

Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

Medicine Products:

Cysticercosis Antibody, IgG by Western Blot (CSF)Cystic Respiratory Culture Cystic Fibrosis, Full Gene Analysis Cystatin C, Serum